S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Aptevo Therapeutics (APVO) Earnings Date, Estimates & Call Transcripts

$0.16
-0.01 (-5.75%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

APVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aptevo Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.78) EPS
Next Year EPS Consensus Estimate: ($1.33) EPS

APVO Earnings Date and Information

Aptevo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates.

Aptevo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/4/2024
Estimated)
------- 
11/14/2023Q3 2023($0.64)($0.50)+$0.14($0.50)--
8/10/2023Q2 2023($1.12)($1.23)($0.11)($1.23)--
5/11/2023Q1 2023($1.19)$0.26+$1.45$0.13--
11/10/2022Q3 2022($1.64)($1.53)+$0.11($1.56)--
8/11/2022Q2 2022($1.33)($1.86)($0.53)($9.30)--
5/12/2022Q1 2022($1.15)($1.59)($0.44)($1.63)$3.75 million$3.11 million    
3/24/2022Q4($1.2950)($1.27)+$0.0250---
11/12/2021Q3 2021($1.48)($1.45)+$0.03($1.47)$3.65 million$3.10 million
8/11/2021Q2($1.84)($1.78)+$0.06($1.81)$2.70 million$3.11 million    
5/11/2021Q1 2021($1.62)($1.74)($0.12)($1.84)$2.10 million$2.42 million
3/30/2021Q4($1.2150)($1.92)($0.7050)---












Aptevo Therapeutics Earnings - Frequently Asked Questions

When is Aptevo Therapeutics's earnings date?

Aptevo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off last year's report dates. Learn more on APVO's earnings history.

How much revenue does Aptevo Therapeutics generate each year?

Aptevo Therapeutics (NASDAQ:APVO) has a recorded annual revenue of $3.11 million.

How much profit does Aptevo Therapeutics generate each year?

Aptevo Therapeutics (NASDAQ:APVO) has a recorded net income of $8.03 million. APVO has generated $0.00 earnings per share over the last four quarters.

What is Aptevo Therapeutics's EPS forecast for next year?

Aptevo Therapeutics's earnings are expected to grow from ($1.78) per share to ($1.33) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:APVO) was last updated on 3/3/2024 by MarketBeat.com Staff